Diabetes: Medtronic taps Schein as exclusive U.S. distributor

Medtronic (NYSE:MDT) said today that it tapped Henry Schein (NSDQ:HSIC) to be its exclusive distributor for some Type II diabetes products in the U.S.

Fridley, Minn.-based Medtronic said the Henry Schein Medical business will distribute the products to primary care physicians here, including its iPro2 Professional continuous glucose monitor and the i-Port Advance injection port.

“Medtronic is committed to advancing the care of people with Type II diabetes. Solutions such as the iPro2 Professional CGM enable physicians to easily gather valuable insights to make educated therapy decisions and improve patient coaching, which can lead to better control for people with Type II diabetes,” non-intensive diabetes therapies general manager Laura Stoltenberg said in prepared remarks. “Together with Henry Schein and its dedicated sales team, we can broaden access to CGM for primary care physicians and their patients with Type II diabetes.”

“Henry Schein’s customers rely on us for the products and services needed to enhance their practice and deliver high-quality patient care,” added Henry Schein Medical president Dave McKinley. “As exclusive distributor of Medtronic’s iPro2 Professional CGM system, along with the i-Port Advance, Henry Schein is pleased to offer our primary care physician customers a complete set of solutions to better care for their patients with Type II diabetes.”

Earlier this week Medtronic launched a new “Pattern Snapshot” report for the iPro2 Professional CGM that’s designed to give healthcare providers a 1-page overview of a patient’s glucose data trends.

The post Diabetes: Medtronic taps Schein as exclusive U.S. distributor appeared first on MassDevice.

from MassDevice http://ift.tt/1IEnEX5